Advertisement

Picture Berlin Partner Events Bionnale 2025 May HealthCapital 650x100px
Organisation › Details

Tagomics Ltd.

Tagomics Ltd., a pioneering biomarker discovery and diagnostics company, has developed a novel multiomics platform, Interlace™, which offers a seamless solution for multiomic profiling to unlock disease-associated DNA biomarkers from a range of biological sources. Based in Cambridge, UK, Tagomics was launched in 2021 as a spin out from The University of Birmingham to build upon research led by Dr Robert Neely, the company’s Chief Scientific Officer. The company has since developed a suite of pioneering 'omics' technologies, including its Interlace multiomic platform, which seamlessly combines the Company’s novel approach to epigenomics (studying chemical 'switches' on the genome) with genomics (detecting mutations and other structural variants) and fragmentomics (the analysis of DNA fragmentation patterns in the blood). By integrating these methods and applying advanced data analysis and machine learning, the Tagomics Interlace platform can provide a 360° understanding of human health and disease. The company aims to discover novel disease markers and apply them to advance diagnostic and drug development. To support this mission, Tagomics has successfully raised over £8 million from investors including Calculus Capital, Illumina Ventures, IQ Capital, Agilent Ventures, Mercia Ventures, Meltwind, OMX Ventures, and Start Codon. *

 

Period Start 2020-07-22 established (s-off)
  Predecessor University of Birmingham
Products Industry multi-omics diagnostics
  Industry 2 Interlace™ multiomics platform (Tagomics)
Persons Person Kennefick, Jack (Tagomics 202402 CEO + Co-Founder)
  Person 2 Naclerio, Nicholas J. (Nick) (Illumina 201512 SVP Corp + Venture before Quanterix + ParAllele + Zymoyx + Motorola)
     
Region Region Cambridge, Cambridgeshire
  Country United Kingdom (GB)
  City CB21 6GQ Cambridge, Cambridgeshire
    Address record changed: 2024-11-24
     
Basic data Employees n. a.
     
    * Document for »About Section«: Tagomics Ltd.. (11/20/24). "Press Release: Tagomics Announces a Multiomic Profiling Co-Marketing Agreement with Agilent". Cambridge.
     
   
Record changed: 2024-11-24

Advertisement

Picture Swiss Biotech Association LSE Swiss Biotech Days 2025 Basel 650x200px

More documents for Tagomics Ltd.


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture EBD Group BIO-Europe Spring 2025 Milan to 28 Feb 650x300px




» top